Columbia Presbyterian Medical Center
New York, New York, United States
Medical center in New York City, New York
630 W 168th St, New York, NY 10032
About Columbia Presbyterian Medical Center
Presbyterian Hospital was a New York City hospital. It was founded in 1868 and began operations in 1872. It was originally located between East 70th Street and 71st Streets and Madison and Park Avenue.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
National Institute of Allergy and Infectious Diseases (NIAID)
45
Columbia University
38
Abbott Medical Devices
26
Edwards Lifesciences
19
Boston Scientific Corporation
13
Children's Oncology Group
11
Centers for Disease Control and Prevention
10
Boehringer Ingelheim
9
Novartis Pharmaceuticals
9
Gilead Sciences
8
Celgene
6
Clinical Trials at Columbia Presbyterian Medical Center
During the past decade, Columbia Presbyterian Medical Center conducted 242 clinical trials. In the 10-year time frame, 242 clinical trials started and 99 clinical trials were completed, i.e. on
average, 40.9% percent of trials that started reached the finish line to date. In the past 5 years, 89 clinical trials started and 52 clinical trials were completed. i.e. 58.4%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Randomized Comparative Trial of Zidovudine (AZT) Versus 2',3'-Dideoxyinosine (ddI) Versus AZT Plus ddI in Symptomatic HIV-Infected Children
1996-09-01
Completed
819
Preventive Treatment Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Confirmed Latent Tuberculous Infection
1999-09-01
Completed
2,000
A Pilot Study Evaluating Penicillin G and Ceftriaxone as Therapies for Presumed Neurosyphilis in HIV Seropositive Individuals
1996-02-01
Completed
100
The Safety and Effectiveness of Methylprednisolone in the Treatment of Pneumocystis Carinii Pneumonia (PCP) in Children With AIDS
Withdrawn
0
A Phase III Randomized, Double-Blind, Controlled Study of the Use of Anti-HIV Immune Serum Globulin (HIVIG) for the Prevention of Maternal-Fetal HIV Transmission in Pregnant Women and Newborns Receiving Zidovudine (AZT)
2007-08-01
Completed
1,600
A Randomized, Double-Blind, Four-Arm Study Comparing Combination Nucleoside, Alternating Nucleoside, and Triple-Drug Therapy for the Treatment of Advanced HIV Disease (CD4 <= 50/mm3)
1996-09-01
Completed
1,292
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Columbia Presbyterian Medical Center" #1 sponsor was "National Institute of Allergy and Infectious Diseases (NIAID)" with 45 trials, followed by "Columbia University" with 38 trials
sponsored, "Abbott Medical Devices" with 26 trials sponsored, "Edwards Lifesciences" with 19 trials sponsored and "Boston Scientific Corporation"
with 19 trials sponsored. Other sponsors include 340 different institutions and
companies that sponsored additional 212 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Columbia Presbyterian Medical Center"
#1 collaborator was "National Cancer Institute (NCI)" with 16 trials as a collaborator, "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 13 trials as a collaborator, "National Institute of Neurological Disorders and Stroke (NINDS)" with 13 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 12 trials as a collaborator and "Columbia University" with 8 trials as a collaborator. Other collaborators include 200 different institutions and companies that were
collaborators in the rest 142 trials.
Clinical Trials Conditions at Columbia Presbyterian Medical Center
According to Clinical.Site data, the most researched conditions in "Columbia Presbyterian Medical Center" are
"HIV Infections" (61 trials), "Coronary Artery Disease" (29 trials), "Heart Failure" (23 trials), "Tuberculosis" (11 trials) and "Stroke" (8 trials). Many other conditions were trialed in "Columbia Presbyterian Medical Center" in a lesser frequency.
Clinical Trials Intervention Types at Columbia Presbyterian Medical Center
Most popular intervention types in "Columbia Presbyterian Medical Center" are "Drug" (215 trials), "Device" (187 trials), "Procedure" (34 trials), "Biological" (31 trials) and "Other" (31 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (39 trials), "Zidovudine" (15 trials), "Didanosine" (12 trials), "Nevirapine" (11 trials) and "Lamivudine" (10 trials). Other intervention names were less common.
Clinical Trials Genders at Columbia Presbyterian Medical Center
The vast majority of trials in "Columbia Presbyterian Medical Center" are
452 trials for "All" genders, 24 trials for "Female" genders and 10 trials for "Male" genders.
Clinical Trials Status at Columbia Presbyterian Medical Center
Currently, there are 154 active trials in "Columbia Presbyterian Medical Center".
4 are not yet recruiting,
91 are recruiting,
55 are Active, not recruiting,
and 4 are Enrolling by invitation.
In total, there were 258 completed trials in Columbia Presbyterian Medical Center,
1 suspended trials,
and 43 terminated clinical trials to date.
Out of the total trials that were conducted in Columbia Presbyterian Medical Center, 40 "Phase 1"
clinical trials were conducted, 117 "Phase 2" clinical
trials and 84 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 16 trials, and there were
also 176 trials that are defined as “Not Applicable".